PubRank

Gunnar Lindeberg

Author PubWeight™ 18.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity. Bioorg Med Chem 2006 0.95
2 A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin II. J Med Chem 2004 0.92
3 Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor. J Med Chem 2007 0.91
4 Discovery of dipeptides with high affinity to the specific binding site for substance P1-7. J Med Chem 2010 0.86
5 Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-Length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals. Bioorg Med Chem 2003 0.84
6 Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP). J Med Chem 2010 0.84
7 In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging. PLoS One 2013 0.82
8 Endomorphin-1 and endomorphin-2 differentially interact with specific binding sites for substance P (SP) aminoterminal SP1-7 in the rat spinal cord. Peptides 2005 0.82
9 New selective AT2 receptor ligands encompassing a gamma-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists. J Med Chem 2005 0.81
10 Small peptides mimicking substance P (1-7) and encompassing a C-terminal amide functionality. Neuropeptides 2008 0.80
11 Endomorphins interact with the substance P (SP) aminoterminal SP(1-7) binding in the ventral tegmental area of the rat brain. Peptides 2008 0.80
12 Design, synthesis, and incorporation of a beta-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT1 and AT2 receptors. J Med Chem 2006 0.80
13 Synthesis and characterization of a high-affinity NOTA-conjugated bombesin antagonist for GRPR-targeted tumor imaging. Bioconjug Chem 2013 0.79
14 Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors. Bioorg Med Chem 2006 0.79
15 Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2. Bioorg Med Chem 2008 0.79
16 Cyclic insulin-regulated aminopeptidase (IRAP)/AT4 receptor ligands. J Pept Sci 2006 0.78
17 A frame shifted disulfide bridged analogue of angiotensin II. Bioorg Med Chem 2003 0.78
18 Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity. J Med Chem 2005 0.78
19 Potent macrocyclic inhibitors of insulin-regulated aminopeptidase (IRAP) by olefin ring-closing metathesis. J Med Chem 2011 0.77
20 AT2-selective angiotensin II analogues containing tyrosine-functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics. J Med Chem 2004 0.77
21 Improved P2 phenylglycine-based hepatitis C virus NS3 protease inhibitors with alkenylic prime-side substituents. Bioorg Med Chem 2010 0.77
22 Vinyl sulfide cyclized analogues of angiotensin II with high affinity and full agonist activity at the AT(1) receptor. J Med Chem 2002 0.77
23 Small potent ligands to the insulin-regulated aminopeptidase (IRAP)/AT(4) receptor. J Pept Sci 2007 0.76
24 Tetrapeptides as potent protease inhibitors of Hepatitis C Virus full-length NS3 (protease-helicase/NTPase). Bioorg Med Chem 2002 0.75
25 Identification of small peptides mimicking the R2 C-terminus of Mycobacterium tuberculosis ribonucleotide reductase. J Pept Sci 2010 0.75
26 Effect of 3-5 monocyclizations of angiotensin II and 4-aminoPhe6-Ang II on AT2 receptor affinity. Bioorg Med Chem 2003 0.75
27 Novel pseudopeptides incorporating a benzodiazepine-based turn mimetic--targeting Mycobacterium tuberculosis ribonucleotide reductase. Bioorg Med Chem 2013 0.75
28 P2-P1' macrocyclization of P2 phenylglycine based HCV NS3 protease inhibitors using ring-closing metathesis. Bioorg Med Chem 2011 0.75